Dahiya, Dushyant Singh, Department of Gastroenterology, University of Kansas Medical Center, Kansas City, KS, United States
-
Vol. 16, No. 6, Dec 2023 - Original Article
Comparing the Efficacy and Safety of Adalimumab and Vedolizumab in Treating Moderate to Severe Crohn's Disease and Ulcerative Colitis
Abstract HTML PDF